A phase 3 trial of the efficacy and safety of bardoxolone methyl in patients with autosomal dominant polycystic kidney disease (FALCON)

  • Ryan, Jessica (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date5/03/20 → 4/03/25

Keywords

  • clinical trial
  • treatment efficacy
  • treatment safety
  • phase 3 study
  • polycystic kidney disease